Overcoming Intrinsic Doxorubicin Resistance in Melanoma by Anti-Angiogenic and Anti-Metastatic Effects of Liposomal Prednisolone Phosphate on Tumor Microenvironment
出版年份 2020 全文链接
标题
Overcoming Intrinsic Doxorubicin Resistance in Melanoma by Anti-Angiogenic and Anti-Metastatic Effects of Liposomal Prednisolone Phosphate on Tumor Microenvironment
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 8, Pages 2968
出版商
MDPI AG
发表日期
2020-04-23
DOI
10.3390/ijms21082968
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
- (2019) Leonie Voorwerk et al. NATURE MEDICINE
- The prednisolone phosphate‑induced suppression of the angiogenic function of tumor‑associated macrophages enhances the antitumor effects of doxorubicin on B16.F10 murine melanoma cells in�vitro
- (2019) Emilia Licarete et al. ONCOLOGY REPORTS
- Doxorubicin inhibits PD-L1 expression by enhancing TTP-mediated decay of PD-L1 mRNA in cancer cells
- (2019) Dong Jun Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Glucocorticoids potentiate the inhibitory capacity of programmed cell death 1 by up-regulating its expression on T cells
- (2019) Natsumi Maeda et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cell death-based treatments of melanoma:conventional treatments and new therapeutic strategies
- (2018) Gianfranco Mattia et al. Cell Death & Disease
- Targeting intracellular MMPs efficiently inhibits tumor metastasis and angiogenesis
- (2018) Yaqi Lv et al. Theranostics
- In Vivo Double Targeting of C26 Colon Carcinoma Cells and Microenvironmental Protumor Processes Using Liposomal Simvastatin
- (2018) Lavinia Luput et al. Journal of Cancer
- Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer
- (2018) Taku Fujimura et al. Frontiers in Oncology
- Combination therapy of simvastatin and 5, 6-dimethylxanthenone-4-acetic acid synergistically suppresses the aggressiveness of B16.F10 melanoma cells
- (2018) Valentin-Florian Rauca et al. PLoS One
- The role of oxidative stress in the biology of melanoma: A systematic review
- (2018) Serafinella Patrizia Cannavò et al. PATHOLOGY RESEARCH AND PRACTICE
- Inflammation and Cancer: Extra- and Intracellular Determinants of Tumor-Associated Macrophages as Tumor Promoters
- (2017) Gabor J. Szebeni et al. MEDIATORS OF INFLAMMATION
- Tumor microenvironment changes leading to resistance of immune checkpoint inhibitors in metastatic melanoma and strategies to overcome resistance
- (2017) Bhargavi Pulluri et al. PHARMACOLOGICAL RESEARCH
- Glucocorticoids promote Von Hippel Lindau degradation and Hif-1α stabilization
- (2017) Andrea Vettori et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HIF-1α acts as a molecular target for simvastatin cytotoxicity in B16.F10 melanoma cells cultured under chemically induced hypoxia
- (2017) Emilia Licarete et al. Oncology Letters
- Tumor-Associated Macrophages Suppress the Cytotoxic Activity of Antimitotic Agents
- (2017) Oakley C. Olson et al. Cell Reports
- Tumor-Associated Macrophages Derived from Circulating Inflammatory Monocytes Degrade Collagen through Cellular Uptake
- (2017) Daniel Hargbøl Madsen et al. Cell Reports
- Pro-tumor activities of macrophages in the progression of melanoma
- (2017) Huafeng Wang et al. Human Vaccines & Immunotherapeutics
- Downregulation of sphingosine kinase-1 induces protective tumor immunity by promoting M1 macrophage response in melanoma
- (2016) Marguerite Mrad et al. Oncotarget
- Tumour hypoxia promotes melanoma growth and metastasis via High Mobility Group Box-1 and M2-like macrophages
- (2016) Roman Huber et al. Scientific Reports
- New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy
- (2016) Qiujun Guo et al. Journal of Immunology Research
- Macrophages and Therapeutic Resistance in Cancer
- (2015) Brian Ruffell et al. CANCER CELL
- Liposomal simvastatin inhibits tumor growth via targeting tumor-associated macrophages-mediated oxidative stress
- (2015) Marius Costel Alupei et al. CANCER LETTERS
- Cellular Mechanisms of Oxidative Stress and Action in Melanoma
- (2015) Mario Venza et al. Oxidative Medicine and Cellular Longevity
- Fibroblasts Protect Melanoma Cells from the Cytotoxic Effects of Doxorubicin
- (2014) Manoela Tiago et al. TISSUE ENGINEERING PART A
- Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis
- (2014) Vladimir Riabov et al. Frontiers in Physiology
- Macrophage Regulation of Tumor Responses to Anticancer Therapies
- (2013) Michele De Palma et al. CANCER CELL
- Recruitment of monocytes/macrophages in different tumor microenvironments
- (2012) Heon-Woo Lee et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Matrix metalloproteinase 2 promotes cell growth and invasion in colorectal cancer
- (2011) W. Dong et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer
- (2011) T. Shree et al. GENES & DEVELOPMENT
- Constitutive HIF-1 activity in malignant melanoma
- (2010) Silke Kuphal et al. EUROPEAN JOURNAL OF CANCER
- Expression and function of hypoxia inducible factor-1 alpha in human melanoma under non-hypoxic conditions
- (2009) Caroline N Mills et al. Molecular Cancer
- Reactive Oxygen Species Regulate Hypoxia-Inducible Factor 1 Differentially in Cancer and Ischemia
- (2008) A. A. Qutub et al. MOLECULAR AND CELLULAR BIOLOGY
- Investigation into the Role of Tumor-Associated Macrophages in the Antitumor Activity of Doxil
- (2008) Manuela Banciu et al. PHARMACEUTICAL RESEARCH
- Antitumor Activity of Liposomal Prednisolone Phosphate Depends on the Presence of Functional Tumor-Associated Macrophages in Tumor Tissue
- (2008) Manuela Banciu et al. NEOPLASIA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started